Yazar "Korkmaz, U." seçeneğine göre listele
Listeleniyor 1 - 20 / 21
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Analysis of Pediatric Patients Requiring PET/CT and Additional Other Nuclear Medicine Methods in the management of cancer(Springer, 2021) Soyluoglu, S.; Korkmaz, U.[Abstract Not Available]Öğe Comparison of dynamic contrast-enhanced MRI parameters with 99mTc-sestamibi uptake ratios in benign thyroid pathologies.(Springer, 2009) Tuncbilek, N.; Sarikaya, A.; Korkmaz, U.; Torun, N.; Aytekin, E.[Abstract Not Available]Öğe Comparison of dynamic contrast-enhanced MRI parameters with 99mTc-sestamibi uptake ratios in malignant bone and soft-tissue tumours.(Springer, 2009) Sarikaya, A.; Tuncbilek, N.; Altaner, S.; Torun, N.; Korkmaz, U.; Yalniz, E.[Abstract Not Available]Öğe Contribution of OSEM Algorithm and Couinaud Segment Analys to Diagnostic Accuracy on Liver Hemangioma Imaging By Using Tc 99m Labeled Red Blood Cells (RBC)(Springer, 2008) Korkmaz, U.; Durmus-Altun, G.; Ustun, F.; Torun, N.; Can, U.[Abstract Not Available]Öğe The contribution of protocol selection to diagnostic accuracy in MIBI parathyroid scintigraphy: reevaluation with SPECT/CT and histopathologic findings(Springer, 2020) Ozdemir, B.; Korkmaz, U.; Soyluoglu, S.; Gokdemir, E.; Altun, G. Durmus[Abstract Not Available]Öğe Correlation between pre-radical prostatectomy Standardized SUVmax ratios detected on 68Ga-PSMA-I&T PET/CT and final histopathology outcomes: An in-depth analysis(Elsevier Espana Slu, 2024) Arikan, M. G.; Soyluoglu, S.; Korkmaz, U.; Tastekin, E.; Elboga, U.; Arda, E.Objective: To evaluate the predictive potential of the maximum standardized uptake value (SUVmax) value of intraprostatic tumors derived from preoperative [Ga- 68 ]Ga-PSMA-I&T PET/CT (SUVT), and its ratios to SUVmax in the liver (SUVTLR) and parotid gland (SUVTPR) with respect to histopathological findings. Materials and methods: Data from patients who underwent radical prostatectomy (RP) for prostate cancer (PC) at our clinic between 2017-2020 were assessed. Patients with a secondary malignancy, a history of transurethral prostate resection, prior treatment for PC, or who received salvage RP were excluded. Whole -body images obtained using the same device, as per the guidelines, were reviewed by two nuclear medicine specialists with more than a decade of experience to reach a consensus for each lesion. The relationships between age, PSA, Prostate Volume, clinical T stage, biopsy International Society of Urological Pathology grade (ISUP), D'amico risk group, intraprostatic tumor volume (HPTV) identified in the final histopathological specimen review, HP-ISUP grade, seminal vesicle invasion (SVI), extracapsular invasion (ECI), positive surgical margine (PSM), SUVT, SUVTLR, and SUVTPR were analyzed. Results: The mean age of the 64 included patients was 64.1 +/- 5.3 y -o. A statistically significant correlation was found between SUVT, SUVTLR, SUVTPR values, and histopathologic stage parameters, such as biopsy ISUP, D'amico Risk Classification, HP-ISUP, HPTV ( P <.05). PSMATV, SUVT, and SUVTLR were statistically significant predictors of extracapsular invasion, while PSA, PSMATV, and SUVTLR were significant predictors of SVI ( P <.05). Conclusion: The standardized SUVT, SUVTLR, and SUVTPR values could be employed as noninvasive markers to assist in predicting postoperative histopathological findings, particularly ECI, SVI, and PSM.Öğe Do Histological Patterns of Primary Tumor Predict Metabolic Patterns detected by FDG PET/CT in Differentiated Thyroid Cancer Patients(Springer, 2020) Soyluoglu, S.; Tastekin, E.; Korkmaz, U.; Orum, S.; Altun, G. Durmus[Abstract Not Available]Öğe Evaluation of Iodine-131 Labelled Lawsone (2-Hydroxy-1,4-Naphthoquinone) Compound's Transdermal and Intravenous Biodistribution(Springer, 2020) Tekin, V.; Korkmaz, U.; Ince, I.; Kutlubay, I.; Altun, G. Durmus; Muftuler, F. Biber[Abstract Not Available]Öğe Evaluation Of Preoperative PET/CT Parameters With Histopathological And Radiological Findings In Colon Cancer(Springer, 2022) Ozdemir, B.; Gunay, B.; Soyluoglu, S.; Korkmaz, U.; Aydin, C.[Abstract Not Available]Öğe Factors Predicting Response and Survival in Lutetium-177 DOTATATE Treatment of Neuroendocrine Tumours: Preliminary Results(Springer, 2023) Mammadkhanli, Z.; Soyluoglu, F.; Gunay, B. Ozdemir; Aydin, C.; Korkmaz, U.[Abstract Not Available]Öğe Ga-68 Psma For The Kidney Function Evaluation: Preliminary Results: Comparison Of Ga-68 Psma Findings With Mag-3 Findings(Springer, 2022) Ozdemir, B.; Korkmaz, U.; Soyluoglu, S.; Durmus-Altun, G.[Abstract Not Available]Öğe Incidental Renal Mass on PET/CT in Lung Cancer Patients, Evaluation With Histopathological Radiological And Clinical Findings: Pearls, Pittfals and False Positivities(Springer, 2021) Ozdemir, B.; Soyluoglu, S.; Korkmaz, U.; Gunay, B.; Uslu, B.; Durmus-Altun, G.[Abstract Not Available]Öğe Normal and Ectopic Lacalized Parathyroid Adenomas: Is There No Difference in Scintigraphic Parameters?(Springer, 2011) Korkmaz, U.; Sarikaya, A.[Abstract Not Available]Öğe PET / CT Imaging in Smoldering Multiple Myeloma Patients F 18-Fluorodeoxyglucose and Ga68-Pentixafor: Preliminary results(Springer, 2020) Korkmaz, U.; Umit, E. G.; Durmus-Altun, G.[Abstract Not Available]Öğe PET/CT in Patients with Cancer of Unknown PrimaryPreliminary Results: Characterization of FDG PET/CT Findings in Occult Lung Cancer and Relation of Results with Pathological Diagnosis and Survival(Springer, 2022) Aslan, A.; Korkmaz, U.; Soyluoglu, S.; Altun, G. Durmus[Abstract Not Available]Öğe Postoperative Radioiodine Ablation in Low-Risk Differentiated Thyroid Cancer: Outcomes of Patients Treated with Different Doses in a Single Center(Springer, 2022) Orun, S.; Soyluoglu, S.; Korkmaz, U.; Ustun, F.[Abstract Not Available]Öğe Relationship of F-18 FDG PET/CT Imaging Findings with Bone Trauma Age(Springer, 2021) Orun, S.; Korkmaz, U.; Soyluoglu, S.; Altun, G. Durmus[Abstract Not Available]Öğe The Relationship Of Lymp Node Distance And Disease Parameters In Prostate Cancer Ga-68 PSMA PET/CT Imaging(Springer, 2023) Aydin, C.; Gunay, B. Ozdemir; Korkmaz, U.; Soyluoglu, F.[Abstract Not Available]Öğe The Role and Impact of 68Ga-PSMA PET/CT in Primary Staging of Prostate Cancer: Preliminary Results in Relation to AJCC Risk Group Staging(Springer, 2018) Aktas, L. Ege; Korkmaz, U.; Akdere, H.; Altun, G. Durmus[Abstract Not Available]Öğe The Role of Ga-68 PSMA PET / CT in Predicting Lu-177 PSMA Effectiveness: Can We Project the Ga-68 DOTA PET / CT and Lu-177 DOTA Treatment Experience to PSMA?(Springer, 2020) Korkmaz, U.; Soyluoglu, F. S.; Durmus-Altun, G.[Abstract Not Available]
